Form 4: Lantheus Holdings CEO Brian Markison Reports Acquisition and Disposal of Common Stock and Stock Options

Sentiment:

SEC Form 4 Filing


CEO Brian Markison reports changes in beneficial ownership of Lantheus Holdings stock, including acquisition of common stock and stock options.

Summary

  • On March 5, 2025, Brian Markison, CEO of Lantheus Holdings, reported acquiring 70,909 shares of common stock.
  • He also disposed of 232,420 shares of common stock.
  • Following these transactions, Markison beneficially owns 232,420 shares of common stock.
  • Additionally, Markison acquired stock options for 41,347 shares of common stock at an exercise price of $100.48, vesting in three equal annual installments beginning March 5, 2026, and expiring on March 5, 2035.
  • These options are directly owned.
  • The reported common stock includes 23,636 restricted stock units vesting over three years and 47,273 performance-based restricted stock units (PSUs) that cliff vest after a three-year performance period, with the ultimate award ranging from 0% to 200% of the target based on performance.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document primarily reports transactions. The disposal of shares could raise concerns, but the acquisition of options suggests confidence. Overall, it's a factual report with mixed signals.

Positives

  • The acquisition of stock options by the CEO could be interpreted as a sign of confidence in the company's future performance.

Negatives

  • The disposal of 232,420 shares of common stock by the CEO could be interpreted negatively by investors.

Risks

  • The value of the performance-based restricted stock units (PSUs) is contingent on the company's performance over a three-year period, introducing uncertainty.

Future Outlook

The vesting of restricted stock units and performance-based stock units is contingent on future performance and continued employment.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding insider transactions, allowing investors to monitor the actions of company executives and directors.

Comparison to Industry Standards

  • Insider transactions are common across publicly traded companies, and the details of these transactions are closely watched by investors.
  • The vesting schedules and performance-based components of the stock options and restricted stock units are typical compensation structures used to align management's interests with those of shareholders.
  • Comparing the size and frequency of insider transactions at Lantheus Holdings to those of its peers (e.g., GE Healthcare, Siemens Healthineers, Philips) can provide insights into the perceived value and future prospects of the company.

Stakeholder Impact

  • Shareholders may react to the reported transactions, potentially influencing the stock price.
  • Employees may be affected by the performance-based stock units, as their value depends on the company's performance.

Key Dates

DateDescription
03/05/2025Date of transaction: acquisition and disposal of common stock and acquisition of stock options.
03/05/2026First vesting date for stock options.
03/05/2035Expiration date for stock options.
03/07/2025Date of signature for the report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.